US Patent Issued to University of South Carolina on May 20 for "Implantation success as determined by blastocoel fluid components" (South Carolina Inventors)

ALEXANDRIA, Va., June 16 -- United States Patent no. 12,305,227, issued on May 20, was assigned to University of South Carolina (Columbia, S.C.).

"Implantation success as determined by blastocoel fluid components" was invented by William Roudebush (Mount Pleasant, S.C.) and Renee Chosed (Greer, S.C.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The current disclosure explains that cfDNA levels, specific gene expression profiles (assessed via altered mRNA levels of specific gene transcripts), specific protein levels, and potentially noncoding RNAs in blastocoel fluid are all factors that can be used to forecast/determine the implantation potential in IVF patients."

The patent was filed on Oct. 7, 2019, unde...